The Microbiome in Immuno-oncology

被引:7
作者
Toker, Joseph [1 ]
Arora, Reetakshi [1 ]
Wargo, Jennifer A. [1 ,2 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA
来源
IMMUNOTHERAPY, 3RD EDITION | 2020年 / 1244卷
关键词
Microbiome; Checkpoint blockade; Immunity; GUT MICROBIOTA; FUSOBACTERIUM-NUCLEATUM; CLOSTRIDIUM-DIFFICILE; DEVELOPING-WORLD; CANCER; THERAPY; TISSUE; TRANSPLANTATION; DIVERSITY; INTERPLAY;
D O I
10.1007/978-3-030-41008-7_19
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The field of cancer therapy has been revolutionized through the use of immunotherapy, and treatment with these therapies now spans from early to late stage, and even into prevention. However, there are still a significant proportion of patients who do not derive long-term benefit from monotherapy and even combined therapy regimens, and novel approaches are needed to enhance therapeutic responses. Additionally, ideal biomarkers of response to immunotherapy are lacking and are critically needed. An emerging area of interest in immuno-oncology (IO) is the microbiome, which refers to the collection of microbes (and their genomes) that inhabit an individual and live in symbiosis. There is now evidence that these microbes (particularly those within the gut) impact host physiology and can impact responses to immunotherapy. The field of microbiome research in immuno-oncology is quickly emerging, with the potential use of the microbiome (in the gut as well as in the tumor) as a biomarker for response to IO as well as a therapeutic target. Notably, the microbiome may even have a role in toxicity to therapy. The state of the science in microbiome and IO are discussed and caveats and future directions are outlined to provide insights as we move forward as a field.
引用
收藏
页码:325 / 334
页数:10
相关论文
共 82 条
[1]   Editorial: Phage Therapy: Past, Presentand Future [J].
Abedon, Stephen T. ;
Garcia, Pilar ;
Mullany, Peter ;
Aminov, Rustam .
FRONTIERS IN MICROBIOLOGY, 2017, 8
[2]  
[Anonymous], 2018, GUT
[3]  
[Anonymous], 2017, BMJ Open Gastroenterology, DOI DOI 10.1136/BMJGAST-2017-000145
[4]   Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota [J].
Arthur, Janelle C. ;
Perez-Chanona, Ernesto ;
Muehlbauer, Marcus ;
Tomkovich, Sarah ;
Uronis, Joshua M. ;
Fan, Ting-Jia ;
Campbell, Barry J. ;
Abujamel, Turki ;
Dogan, Belgin ;
Rogers, Arlin B. ;
Rhodes, Jonathan M. ;
Stintzi, Alain ;
Simpson, Kenneth W. ;
Hansen, Jonathan J. ;
Keku, Temitope O. ;
Fodor, Anthony A. ;
Jobin, Christian .
SCIENCE, 2012, 338 (6103) :120-123
[5]   The ovarian cancer oncobiome [J].
Banerjee, Sagarika ;
Tian, Tian ;
Wei, Zhi ;
Shih, Natalie ;
Feldman, Michael D. ;
Alwine, James C. ;
Coukos, George ;
Robertson, Erle S. .
ONCOTARGET, 2017, 8 (22) :36225-36245
[6]   Fecal microbiota transplantation (FMT) and re-induction of anti-PD-1 therapy in refractory metastatic melanoma patients - preliminary results from a phase I clinical trial (NCT03353402) [J].
Baruch, Erez N. ;
Youngster, Ilan ;
Ortenberg, Rona ;
Ben-Betzalel, Guy ;
Katz, Lior H. ;
Lahat, Adi ;
Barshack, Iris ;
Dick-Necula, Daniela ;
Mamtani, Ronac ;
Bloch, Naamah ;
Ungar, Bella ;
Rotin, Daniel ;
Avivi, Camila ;
Anafi, Liat ;
Steinberg-Silman, Yael ;
Asher, Nethanel ;
Shapira-Frommer, Ronnie ;
Brosh-Nissimov, Tal ;
Eshet, Yael ;
Raskin, Stephen ;
Harati, Hagit ;
MeInichenko, Jenny ;
Schachter, Jacob ;
Koren, Omry ;
Markel, Gal ;
Boursi, Ben .
CANCER RESEARCH, 2019, 79 (13)
[7]   Role of the Microbiota in Immunity and Inflammation [J].
Belkaid, Yasmine ;
Hand, Timothy W. .
CELL, 2014, 157 (01) :121-141
[8]   Compartmentalized and systemic control of tissue immunity by commensals [J].
Belkaid, Yasmine ;
Naik, Shruti .
NATURE IMMUNOLOGY, 2013, 14 (07) :646-653
[9]   Recurrent antibiotic exposure may promote cancer formation - Another step in understanding the role of the human microbiota? [J].
Boursi, Ben ;
Mamtani, Ronac ;
Haynes, Kevin ;
Yang, Yu-Xiao .
EUROPEAN JOURNAL OF CANCER, 2015, 51 (17) :2655-2664
[10]   LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells [J].
Brand, Almut ;
Singer, Katrin ;
Koehl, Gudrun E. ;
Kolitzus, Marlene ;
Schoenhammer, Gabriele ;
Thiel, Annette ;
Matos, Carina ;
Bruss, Christina ;
Klobuch, Sebastian ;
Peter, Katrin ;
Kastenberger, Michael ;
Bogdan, Christian ;
Schleicher, Ulrike ;
Mackensen, Andreas ;
Ullrich, Evelyn ;
Fichtner-Feigl, Stefan ;
Kesselring, Rebecca ;
Mack, Matthias ;
Ritter, Uwe ;
Schmid, Maximilian ;
Blank, Christian ;
Dettmer, Katja ;
Oefner, Peter J. ;
Hoffmann, Petra ;
Walenta, Stefan ;
Geissler, Edward K. ;
Pouyssegur, Jacques ;
Villunger, Andreas ;
Steven, Andre ;
Seliger, Barbara ;
Schreml, Stephan ;
Haferkamp, Sebastian ;
Kohl, Elisabeth ;
Karrer, Sigrid ;
Berneburg, Mark ;
Herr, Wolfgang ;
Mueller-Klieser, Wolfgang ;
Renner, Kathrin ;
Kreutz, Marina .
Cell Metabolism, 2016, 24 (05) :657-671